Product
CD19CAR-28-zeta T cells
1 clinical trial
3 indications
Indication
B-cell LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
Acute Lymphocytic LeukemiaClinical trial
Phase I Study Of CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, Acute Lymphocytic Leukemia, and Chronic Lymphocytic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2014-07-01